Cargando…
Correlation Between CT Features of Active Tuberculosis and Residual Metabolic Activity on End-of-Treatment FDG PET/CT in Patients Treated for Pulmonary Tuberculosis
Patients who complete a standard course of anti-tuberculous treatment (ATT) for pulmonary tuberculosis and are declared cured according to the current standard of care commonly have residual metabolic activity (RMA) in their lungs on fluorine-18 fluorodeoxyglucose positron emission tomography/comput...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920557/ https://www.ncbi.nlm.nih.gov/pubmed/35295606 http://dx.doi.org/10.3389/fmed.2022.791653 |
_version_ | 1784669153310801920 |
---|---|
author | Lawal, Ismaheel O. Mokoala, Kgomotso M. G. Mathebula, Matsontso Moagi, Ingrid Popoola, Gbenga O. Moeketsi, Nontando Nchabeleng, Maphoshane Hikuam, Chris Ellner, Jerrold J. Hatherill, Mark Fourie, Bernard P. Sathekge, Mike M. |
author_facet | Lawal, Ismaheel O. Mokoala, Kgomotso M. G. Mathebula, Matsontso Moagi, Ingrid Popoola, Gbenga O. Moeketsi, Nontando Nchabeleng, Maphoshane Hikuam, Chris Ellner, Jerrold J. Hatherill, Mark Fourie, Bernard P. Sathekge, Mike M. |
author_sort | Lawal, Ismaheel O. |
collection | PubMed |
description | Patients who complete a standard course of anti-tuberculous treatment (ATT) for pulmonary tuberculosis and are declared cured according to the current standard of care commonly have residual metabolic activity (RMA) in their lungs on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PER/CT) imaging. RMA seen in this setting has been shown to be associated with relapse of tuberculosis. The routine clinical use of FDG PET/CT imaging for treatment response assessment in tuberculosis is hindered by cost and availability. CT is a more readily available imaging modality. We sought to determine the association between CT features suggestive of active tuberculosis and RMA on FDG PET/CT obtained in patients who completed a standard course of ATT for pulmonary tuberculosis. We prospectively recruited patients who completed a standard course of ATT and declared cured based on negative sputum culture. All patients had FDG PET/CT within 2 weeks of completing ATT. We determined the presence of RMA on FDG PET images. Among the various lung changes seen on CT, we considered the presence of lung nodule, consolidation, micronodules in tree-in-bud pattern, FDG-avid chest nodes, and pleural effusion as suggestive of active tuberculosis. We determine the association between the presence of RMA on FDG PET and the CT features of active tuberculosis. We include 75 patients with a mean age of 36.09 ± 10.49 years. Forty-one patients (54.67%) had RMA on their FDG PET/CT while 34 patients (45.33%) achieved complete metabolic response to ATT. There was a significant association between four of the five CT features of active disease, p < 0.05 in all cases. Pleural effusion (seen in two patients) was the only CT feature of active disease without a significant association with the presence of RMA. This suggests that CT may be used in lieu of FDG PET/CT for treatment response assessment of pulmonary tuberculosis. |
format | Online Article Text |
id | pubmed-8920557 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89205572022-03-15 Correlation Between CT Features of Active Tuberculosis and Residual Metabolic Activity on End-of-Treatment FDG PET/CT in Patients Treated for Pulmonary Tuberculosis Lawal, Ismaheel O. Mokoala, Kgomotso M. G. Mathebula, Matsontso Moagi, Ingrid Popoola, Gbenga O. Moeketsi, Nontando Nchabeleng, Maphoshane Hikuam, Chris Ellner, Jerrold J. Hatherill, Mark Fourie, Bernard P. Sathekge, Mike M. Front Med (Lausanne) Medicine Patients who complete a standard course of anti-tuberculous treatment (ATT) for pulmonary tuberculosis and are declared cured according to the current standard of care commonly have residual metabolic activity (RMA) in their lungs on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PER/CT) imaging. RMA seen in this setting has been shown to be associated with relapse of tuberculosis. The routine clinical use of FDG PET/CT imaging for treatment response assessment in tuberculosis is hindered by cost and availability. CT is a more readily available imaging modality. We sought to determine the association between CT features suggestive of active tuberculosis and RMA on FDG PET/CT obtained in patients who completed a standard course of ATT for pulmonary tuberculosis. We prospectively recruited patients who completed a standard course of ATT and declared cured based on negative sputum culture. All patients had FDG PET/CT within 2 weeks of completing ATT. We determined the presence of RMA on FDG PET images. Among the various lung changes seen on CT, we considered the presence of lung nodule, consolidation, micronodules in tree-in-bud pattern, FDG-avid chest nodes, and pleural effusion as suggestive of active tuberculosis. We determine the association between the presence of RMA on FDG PET and the CT features of active tuberculosis. We include 75 patients with a mean age of 36.09 ± 10.49 years. Forty-one patients (54.67%) had RMA on their FDG PET/CT while 34 patients (45.33%) achieved complete metabolic response to ATT. There was a significant association between four of the five CT features of active disease, p < 0.05 in all cases. Pleural effusion (seen in two patients) was the only CT feature of active disease without a significant association with the presence of RMA. This suggests that CT may be used in lieu of FDG PET/CT for treatment response assessment of pulmonary tuberculosis. Frontiers Media S.A. 2022-02-22 /pmc/articles/PMC8920557/ /pubmed/35295606 http://dx.doi.org/10.3389/fmed.2022.791653 Text en Copyright © 2022 Lawal, Mokoala, Mathebula, Moagi, Popoola, Moeketsi, Nchabeleng, Hikuam, Ellner, Hatherill, Fourie and Sathekge. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Lawal, Ismaheel O. Mokoala, Kgomotso M. G. Mathebula, Matsontso Moagi, Ingrid Popoola, Gbenga O. Moeketsi, Nontando Nchabeleng, Maphoshane Hikuam, Chris Ellner, Jerrold J. Hatherill, Mark Fourie, Bernard P. Sathekge, Mike M. Correlation Between CT Features of Active Tuberculosis and Residual Metabolic Activity on End-of-Treatment FDG PET/CT in Patients Treated for Pulmonary Tuberculosis |
title | Correlation Between CT Features of Active Tuberculosis and Residual Metabolic Activity on End-of-Treatment FDG PET/CT in Patients Treated for Pulmonary Tuberculosis |
title_full | Correlation Between CT Features of Active Tuberculosis and Residual Metabolic Activity on End-of-Treatment FDG PET/CT in Patients Treated for Pulmonary Tuberculosis |
title_fullStr | Correlation Between CT Features of Active Tuberculosis and Residual Metabolic Activity on End-of-Treatment FDG PET/CT in Patients Treated for Pulmonary Tuberculosis |
title_full_unstemmed | Correlation Between CT Features of Active Tuberculosis and Residual Metabolic Activity on End-of-Treatment FDG PET/CT in Patients Treated for Pulmonary Tuberculosis |
title_short | Correlation Between CT Features of Active Tuberculosis and Residual Metabolic Activity on End-of-Treatment FDG PET/CT in Patients Treated for Pulmonary Tuberculosis |
title_sort | correlation between ct features of active tuberculosis and residual metabolic activity on end-of-treatment fdg pet/ct in patients treated for pulmonary tuberculosis |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920557/ https://www.ncbi.nlm.nih.gov/pubmed/35295606 http://dx.doi.org/10.3389/fmed.2022.791653 |
work_keys_str_mv | AT lawalismaheelo correlationbetweenctfeaturesofactivetuberculosisandresidualmetabolicactivityonendoftreatmentfdgpetctinpatientstreatedforpulmonarytuberculosis AT mokoalakgomotsomg correlationbetweenctfeaturesofactivetuberculosisandresidualmetabolicactivityonendoftreatmentfdgpetctinpatientstreatedforpulmonarytuberculosis AT mathebulamatsontso correlationbetweenctfeaturesofactivetuberculosisandresidualmetabolicactivityonendoftreatmentfdgpetctinpatientstreatedforpulmonarytuberculosis AT moagiingrid correlationbetweenctfeaturesofactivetuberculosisandresidualmetabolicactivityonendoftreatmentfdgpetctinpatientstreatedforpulmonarytuberculosis AT popoolagbengao correlationbetweenctfeaturesofactivetuberculosisandresidualmetabolicactivityonendoftreatmentfdgpetctinpatientstreatedforpulmonarytuberculosis AT moeketsinontando correlationbetweenctfeaturesofactivetuberculosisandresidualmetabolicactivityonendoftreatmentfdgpetctinpatientstreatedforpulmonarytuberculosis AT nchabelengmaphoshane correlationbetweenctfeaturesofactivetuberculosisandresidualmetabolicactivityonendoftreatmentfdgpetctinpatientstreatedforpulmonarytuberculosis AT hikuamchris correlationbetweenctfeaturesofactivetuberculosisandresidualmetabolicactivityonendoftreatmentfdgpetctinpatientstreatedforpulmonarytuberculosis AT ellnerjerroldj correlationbetweenctfeaturesofactivetuberculosisandresidualmetabolicactivityonendoftreatmentfdgpetctinpatientstreatedforpulmonarytuberculosis AT hatherillmark correlationbetweenctfeaturesofactivetuberculosisandresidualmetabolicactivityonendoftreatmentfdgpetctinpatientstreatedforpulmonarytuberculosis AT fouriebernardp correlationbetweenctfeaturesofactivetuberculosisandresidualmetabolicactivityonendoftreatmentfdgpetctinpatientstreatedforpulmonarytuberculosis AT sathekgemikem correlationbetweenctfeaturesofactivetuberculosisandresidualmetabolicactivityonendoftreatmentfdgpetctinpatientstreatedforpulmonarytuberculosis |